Skip to main content
. 2018 Jan 31;10(2):40. doi: 10.3390/cancers10020040

Figure 2.

Figure 2

Effect of sFRP4 on CSC viability: Viability assay was performed using Cell Counting Kit-8 after treatment of CSCs derived from (A) MDA231; (B) MCF7; (C) PC-3; and (D) LnCap cell lines treated with sFRP4 for 24 h. Statistical analysis was performed using ANOVA for analysis variance with Bonferroni test for comparison showing significance as *** p < 0.001; ** p < 0.01; * p < 0.05. Data are mean ± standard error of mean from three independent experiments.